Monitor future quarters for sustained momentum in Canada, where recent retail expansion could drive growth. The small market cap makes IMRN sensitive to sales execution; any slowdown in growth could lead to sharp downside, while continued expansion could attract speculative interest.
Price Chart
Executive Summary
Immuron Ltd reported unaudited Q3 sales growth of 16% year-over-year to AUD$1.5 million, driven by strong performance in Australia (+15%) and Canada (>100% YoY, +82% QoQ). The U.S. showed minimal growth (+1%), while Canada's YTD sales declined 65% due to prior period comparisons. The stock, with a $6M market cap, may react positively to the double-digit growth and expansion into key Canadian retail channels.
Key Facts
- Q3 global sales: AUD$1.5 million, up 16% YoY
- YTD sales (Mar 2026): AUD$5.7 million, up 7% YoY
- Australia Q3 sales: AUD$0.9 million, up 15% YoY
- Canada Q3 sales: AUD$0.1 million, up >100% YoY and 82% QoQ due to Jean Coutu launch
- USA Q3 sales: AUD$0.5 million, up 1% YoY
- Company attributes growth to marketing, new store listings, and travel recovery
Financial Impact
16% year-over-year revenue growth in Q3 to AUD$1.5 million (~$1.01M USD), with Australia contributing 60% of global sales
Risk Factors
- Canada YTD sales down 65% YoY suggests difficult prior-year comparisons or initial stocking effects
- U.S. growth stalled at 1% despite marketing initiatives, offset by AUD/USD exchange headwinds
- Company is small-cap ($6M) with limited liquidity, increasing volatility risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-044867 |
| Document: ea0286782-6k_immuron.htm | 0001213900-26-044867 |
| Document: 0001213900-26-044867-index-headers.html | 0001213900-26-044867 |
| Document: 0001213900-26-044867-index.html | 0001213900-26-044867 |
| Document: 0001213900-26-044867.txt | 0001213900-26-044867 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $0.9300 | awaiting T+60 | — | $0.9302 (+0.02%) |
Oct 23, 2026 4d ago | 6-K | $0.9200 | awaiting T+60 | — | $0.9302 (+1.11%) |
Oct 23, 2026 4d ago | 424B5 | $0.9200 | awaiting T+60 | — | $0.9302 (+1.11%) |
Oct 21, 2026 5d ago | 6-K | $0.9490 | awaiting T+60 | — | $0.9302 (−1.98%) |
Oct 16, 2026 11d ago | 6-K | $0.9821 | awaiting T+60 | — | $0.9302 (−5.28%) |
Oct 13, 2026 14d ago | 6-K | $1.04 | awaiting T+60 | — | $0.9302 (−10.56%) |
Sep 24, 2026 4w ago | 20-F | $1.19 | awaiting T+60 | — | $0.9302 (−21.83%) |
Sep 24, 2026 4w ago | 6-K | $1.19 | awaiting T+60 | — | $0.9302 (−21.83%) |
Sep 21, 2026 5w ago | 6-K | $1.26 | awaiting T+60 | — | $0.9302 (−25.88%) |
Sep 4, 2026 7w ago | Press Release | $1.80 | awaiting T+60 | — | $0.9302 (−48.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers